To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.

View sample alert

Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Departmental Publication (Statistics)
Department for Work and Pensions

Mar. 21 2024

Source Page: Review of the UK Material Deprivation Measures
Document: Review of the UK Material Deprivation Measures (PDF)

Found: to dentists or opticians) due to inability to afford costs, as well as problems in keeping up with medical

Non-Departmental Publication (News and Communications)
Intellectual Property Office

Mar. 19 2024

Source Page: Report launched into UK's IP-backed finance landscape
Document: new report launched in London today (PDF)

Found: Accountants BBB British Business Bank BVCA British Private Equity and Venture Capital Association CBILS Coronavirus

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 4 December 2023
Document: FOI 23/774 - attachment 2 (PDF)

Found: ZENECA is indicated for active immunizat ion of individuals ≥18 years ol d for the prevent ion of coronavirus

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 18 December 2023
Document: FOI 23/905 - attachment 3 (PDF)

Found: SARS -CoV-2 (severe acute respiratory syndrome coronavirus 2) causes coronavirus disease 2019 (COVID

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 18 December 2023
Document: FOI 23/905 - attachment 9 (PDF)

Found: Conditional Approval Active Surveillance Study Among Individuals in Europe Receiving the Pfizer -BioNTech Coronavirus

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 18 December 2023
Document: FOI 23/905 - attachment 8 (PDF)

Found: Conditional Approval Active Surveillance Study Among Individuals in Europe Receiving the Pfizer -BioNTech Coronavirus

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 18 December 2023
Document: FOI 23/905 - attachment 6 (PDF)

Found: Conditional Approval Active Surveillance Study Among Individuals in Europe Receiving the Pfizer -BioNTech Coronavirus

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 18 December 2023
Document: FOI 23/905 - attachment 2 (PDF)

Found: SARS -CoV-2 (severe acute respiratory syndrome coronavirus 2) causes coronavirus disease 2019 (COVID

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 18 December 2023
Document: FOI 23/905 - attachment 4 (PDF)

Found: severe acute respiratory syndrome coronavirus 2 (SARS -CoV-2) causes coronavirus disease 2019 (COVID

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 18 December 2023
Document: FOI 23/905 - attachment 7 (PDF)

Found: Conditional Approval Active Surveillance Study Among Individuals in Europe Receiving the Pfizer- BioNTech Coronavirus